| 产品描述: | SPL-707 is an orally active, selective signal peptide peptidase-like 2a (SPPL2a) inhibitor with an IC50 of 77 nM for hSPPL2a. SPL-707 inhibits γ-secretase (IC50=6.1 μM) and SPP (IC50=3.7 μM). SPL-707 has the potential for autoimmune diseases research by targeting B cells and dendritic cells. |
| 体内研究: |
SPL-707 (Compound 40) 抑制小鼠 SPPL2a (IC50=0.18 μM)、大鼠 SPPL2a (IC50=0.056 μM) 和人 SPPL2a (IC50=0.16 μM),人 SPPL2b (IC50=0.43 μM) 通过高内涵成像分析 (HCA)。 |
| 参考文献: |
1. Velcicky J, et al. Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo. J Med Chem. 2018 Feb 8;61(3):865-880. |
| 保存条件: |
-80°C 24个月;-20°C 12个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.978 ml |
9.89 ml |
19.781 ml |
| 5 mM |
0.396 ml |
1.978 ml |
3.956 ml |
| 10 mM |
0.198 ml |
0.989 ml |
1.978 ml |
| 50 mM |
0.04 ml |
0.198 ml |
0.396 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |